Adaptimmune Ltd - Company Profile

Powered by

All the data and insights you need on Adaptimmune Ltd in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Adaptimmune Ltd Strategy Report

  • Understand Adaptimmune Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Adaptimmune Ltd: Overview

Select Item

Adaptimmune Ltd (Adaptimmune), a subsidiary of Adaptimmune Therapeutics plc is a biopharmaceutical company. It includes developing T-cell receptors for T-cell therapy and SPEAR TCR therapies to utilize the body’s immune system. Adaptimmune’s product pipeline includes ADP-A2M10 (MAGE-A10) for melanoma, urothelial cancer, ADP-A2M4 (MAGE-A4) for synovial sarcoma, myxoid cell liposarcoma, ovarian cancer, ADP-A2AFP (AFP) for liver cancer. Its clinical trials include multiple myeloma trial, synovial sarcoma trial, ovarian cancer trial, non-small cell lung cancer (NSCLC). The company also provides pre-clinical testing to minimize cross-reactivity of the products. Adaptimmune is headquartered in Abingdon, Oxfordshire, the UK.

 Gain a 360-degree view of Adaptimmune Ltd and make more informed decisions for your business Gain a 360-degree view of Adaptimmune Ltd and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address 60 Jubilee Avenue, Milton Park, Abingdon, England, OX144RX
Website www.adaptimmune.com
Telephone 44 1235 430000
No of Employees 298
Industry Pharmaceuticals and Healthcare
Revenue (2022) $27.3M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Products and Services

Products Services
T-cell therapy Health Care Services
SPEAR TCR therapies
ADP-A2M4CD8 SPEAR T-Cell Therapy
Understand Adaptimmune Ltd portfolio and identify potential areas for collaboration Understand Adaptimmune Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Adaptimmune Ltd Benevolentai Cambridge Ltd Bicycle Therapeutics Plc Mina Therapeutics Ltd Advinia Health Care Ltd
Headquarters United Kingdom United Kingdom United Kingdom United Kingdom United Kingdom
City Abingdon London Cambridge London London
State/Province England England Cambridgeshire England England
No. of Employees 298 42 236 18 -
Entity Type Private Private Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
David M Mott Chairman Executive Board - -
Adrian Rawcliffe Chief Executive Officer; Director Executive Board - -
Wood Gavin Chief Financial Officer; Director Executive Board 2020 54
Henry Margaret Director; Secretary Executive Board 2014 55
William Bertrand Chief Operating Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into Adaptimmune Ltd key executives to enhance your sales strategy Gain insight into Adaptimmune Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?